The research project prepared by Lazarski University presents a proposal for a new solution to improve Polish patients’ access to modern drug technologies, in particular in the treatment of cancer. The report discusses the advantages and limitations of existing international and Polish solutions, presents the results of cost and value analyzes of drug technologies, and then comprehensively illustrates the new WDTL+ mechanism, which would complement the currently existing emergency access to drug technologies (RDTL). The report was positively reviewed, among others, by Prof. M.D., Ph.D. Maciej Krzakowski, Prof. Ph.D. med. Piotr Rutkowski, Prof. Piotr Czauderna, prof. Ph.D. med. Ewa Lech-Marańda and prof. Ph.D. med. Ewa Lech-Marańda

 

Proposal of a new mechanism for early and conditional access to anticancer and innovative drug technologies (WDTL+) PDF (In Polish)